Toggle Offcanvas
...
 
Etanercept Tenders

Etanercept Tenders

View Etanercept tenders, RFPs and contracts. Bid on readily available Etanercept tenders with the best and most comprehensive tendering platform, since 2002.
Etanercept is a biologic medication that blocks tumor necrosis factor TNF , a substance involved in inflammation. It is primarily used for autoimmune conditions like rheumatoid arthritis and psoriasis.

Bidding for Etanercept tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Etanercept.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Etanercept market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Etanercept tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

147 Live Notices for Etanercept Tenders

Showing 1 to 20

0000459/2025 Framework Agreement With Several Companies, Which Establishes The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilars Intended For The Health Centers Of The Andalusian Health Service.
country Spain
posting date20 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies Which Set The Conditions For The Supply, In A Harmonized And Homogeneous Way In All The Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date16 Oct 2025
deadline03 Nov 2025
0000459/2025 Framework Agreement With Several Companies, Which Establishes The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilars Intended For The Health Centers Of The Andalusian Health Service.
country Spain
posting date15 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies That Establishes The Conditions For The Supply, In A Harmonized And Homogeneous Manner In All Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through An Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date14 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies Which Set The Conditions For The Supply, In A Harmonized And Homogeneous Way In All The Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date14 Oct 2025
deadline03 Nov 2025
0000459/2025 Framework Agreement With Several Companies, Which Establishes The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilars Intended For The Health Centers Of The Andalusian Health Service.
country Spain
posting date14 Oct 2025
deadline03 Nov 2025
0000459/2025 Framework Agreement With Several Companies, Which Establishes The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilars Intended For The Health Centers Of The Andalusian Health Service.
country Spain
posting date10 Oct 2025
deadline03 Nov 2025
Supply Framework Agreement (Contr 2025 0000563560)
country Spain
posting date10 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies That Establishes The Conditions For The Supply, In A Harmonized And Homogeneous Manner In All Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through An Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date10 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies Which Set The Conditions For The Supply, In A Harmonized And Homogeneous Way In All The Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date09 Oct 2025
deadline03 Nov 2025
0000459/2025 Framework Agreement With Several Companies, Which Sets The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilar For The Health Centers Of The Andalusian Health Service.
country Spain
posting date08 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies Which Set The Conditions For The Supply, In A Harmonized And Homogeneous Way In All The Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date08 Oct 2025
deadline03 Nov 2025
0000772/2025 Framework Agreement With Several Companies That Establishes The Conditions For The Supply, In A Harmonized And Homogeneous Manner In All Centers Of The Provincial Purchasing Center Of Almería, Of Biological And Biosimilar Medicines, With The Same Degree Of Efficiency (Adalimumab, Etanercept, Infliximab, Pegfilgrastim And Ustekinumab), Through An Open Procedure. Subject To Harmonized Regulation. Electronic Submission Of Offers.
country Spain
posting date08 Oct 2025
deadline03 Nov 2025
0000459/2025 Framework Agreement With Several Companies, Which Sets The Conditions For The Supply Of Original Or Reference Biological Medicines And Biosimilar For The Health Centers Of The Andalusian Health Service.
country Spain
posting date02 Oct 2025
deadline03 Nov 2025
Medicines With The Active Ingredient Etannercept (Atc: L04Ab01)
country Germany
posting date17 Sep 2025
deadline31 Aug 2027
Medicines With The Active Ingredient Etannercept (Atc: L04Ab01)
country Germany
posting date17 Sep 2025
deadline31 Aug 2027
Open House Biologika Discount Contracts 2025-23-Etanercept
country Germany
posting date19 Aug 2025
deadline30 Sep 2027
Open House Biologika Discount Contracts 2025-23-Etanercept
country Germany
posting date16 Aug 2025
deadline30 Sep 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Etanercept (Atc Code According To Who: L04Ab01)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Etanercept (Atc Code According To Who: L04Ab01)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026

Share Share this page